520079·Stock-Sector-Healthcare
MiraeAsset Leverage US Pharma TOP3 ETN
Introduction
This ETN invests in 2x leveraged positions in the top 3 U.S.-listed large pharmaceutical companies by market capitalization.
Benchmark Index
Bloomberg US Pharma Top 3 EW 2x Daily Leveraged Net Return Index
Benchmark Index Description
The index provides 2x leveraged long exposure to the Underlying Index, taking into account the funding cost with funding percentage of 100%.
Issuer
MIRAE ASSET SECURITIES CO.,LTD.
Brand
미래에셋
Total Fee
0.8
Listing Date
2024-09-20
International Securities Code
KRG520000792
Market Information
Market Capitalization
29,395,000,000KRW
Transaction Amount
147,060KRW
Trading Volume
5
Shares Outstanding
1,000,000
IV
29,247.98
52-Week High
29,950KRW
52-Week Low
11,465KRW